Basics |
Company: |
Exact Sciences Corporation |
IPO Date: |
January 31, 2001 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$9.13B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.75 | 2.72%
|
Avg Daily Range (30 D): |
$0.98 | 1.77%
|
Avg Daily Range (90 D): |
$1.00 | 1.71%
|
Institutional Daily Volume |
Avg Daily Volume: |
1.19M |
Avg Daily Volume (30 D): |
1.78M |
Avg Daily Volume (90 D): |
1.91M |
Trade Size |
Avg Trade Size (Sh.): |
104 |
Avg Trade Size (Sh.) (30 D): |
64 |
Avg Trade Size (Sh.) (90 D): |
67 |
Institutional Trades |
Total Inst.Trades: |
18,238 |
Avg Inst. Trade: |
$3.08M |
Avg Inst. Trade (30 D): |
$2.98M |
Avg Inst. Trade (90 D): |
$3.28M |
Avg Inst. Trade Volume: |
.05M |
Avg Inst. Trades (Per Day): |
6 |
Market Closing Trades |
Avg Closing Trade: |
$9.65M |
Avg Closing Trade (30 D): |
$15M |
Avg Closing Trade (90 D): |
$17.05M |
Avg Closing Volume: |
165.71K |
|
|
|
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$-1.16
|
$-.21
|
$-.09
|
Diluted EPS
|
$-1.16
|
$-.21
|
$-.09
|
Revenue
|
$ 2.69B
|
$ 708.66M
|
$ 699.26M
|
Gross Profit
|
$ 1.96B
|
$ 512.59M
|
$ 509.42M
|
Net Income / Loss
|
$ -214.04M
|
$ -38.24M
|
$ -15.81M
|
Operating Income / Loss
|
$ -240.19M
|
$ -39.4M
|
$ -26.26M
|
Cost of Revenue
|
$ 727.88M
|
$ 196.07M
|
$ 189.85M
|
Net Cash Flow
|
$ -.24M
|
$ 58.65M
|
$ 184.23M
|
PE Ratio
|
|
|
|
|